Inventiva (IVA) FCF Payout Ratio (2019 - 2022)
Inventiva (IVA) posted quarterly FCF Payout Ratio of 2.95 for Q4 2022, up 38.2% year-over-year from 2.13 in Q4 2021, and little changed quarter-over-quarter from 2.95 in Q3 2022.
Inventiva (IVA) FCF Payout Ratio (2019 - 2022) Analysis & Trends
Inventiva's FCF Payout Ratio history runs 4 years deep, the most recent figure standing at 2.95 for Q4 2022.
- In Q4 2022, FCF Payout Ratio rose 38.2% year-over-year to 2.95; the TTM figure through Dec 2022 stood at 3.26 (up 36.87% YoY), while the FY2022 annual figure was 1.71, up 13.21% from the prior year.
- FCF Payout Ratio for Q4 2022 stood at 2.95, roughly flat from 2.95 in the prior quarter.
- The five-year high for FCF Payout Ratio was 1.19 in Q2 2021, with the low at 13.93 in Q1 2021.
- The 4-year median for FCF Payout Ratio is 2.95 (2022), against an average of 5.25.
- The sharpest annual moves came in 2020 and 2021: FCF Payout Ratio plunged 264.23% in 2020, then soared 179.56% in 2021.
- Inventiva's FCF Payout Ratio stood at 2.0 in 2019, then slumped by 264.23% to 7.29 in 2020, then soared by 34.57% to 4.77 in 2021, then soared by 38.2% to 2.95 in 2022.
- Business Quant data shows IVA's FCF Payout Ratio at 2.95 in Q4 2022, 2.95 in Q3 2022, and 4.77 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.17 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.07 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -2.95 |
| Sep 22, 2022 | -2.95 |
| Dec 31, 2021 | -4.77 |
| Jun 30, 2021 | 1.19 |
| Mar 31, 2021 | -13.93 |
| Dec 31, 2020 | -7.29 |
| Jun 30, 2020 | -1.50 |
| Mar 31, 2020 | -13.10 |
| Dec 31, 2019 | -2.00 |